Clinical Trial Update: Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating continuous intravenous ketamine for refractory cancer pain in terminally ill patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain
• Terminal Illness or Terminal Cancer

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Pusan National University Yangsan Hospital | Conditions: Ketamine, Refractory Cancer Pain | Phase 2 | Status: UNKNOWN